StockWatch
·
Pharmaceuticals
Board Meeting26 Oct 2026, 02:50 pm

Kopran Ltd Board Meeting on Nov 3 to Approve Q2 FY27 Results

AI Summary

Kopran Ltd has announced a Board of Directors meeting scheduled for November 3, 2026. The primary agenda is to consider and approve the unaudited standalone and consolidated financial results for the second quarter ended September 30, 2026. The trading window for securities, which was closed from October 1, 2026, will reopen 48 hours after the declaration of these financial results.

Key Highlights

  • Board meeting scheduled for November 3, 2026.
  • To approve unaudited standalone and consolidated financial results.
  • Results for the second quarter ended September 30, 2026.
  • Trading window to reopen 48 hours post-results declaration.